Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 4 of 4 entries
View as:
Phase: N/A
Priority: Normal
Start: 05/19/21
End: 03/14/23
Due: 03/14/24
Phase: N/A
Priority: Normal
Start: 12/16/19
End: 09/15/20
Due: 09/15/21
Phase: N/A
Priority: Normal
Start: 05/19/21
End: 08/03/21
Due: 08/03/22
Phase: N/A
Priority: Normal
Start: 03/15/18
End: 08/15/18
Due: 08/15/19
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| ALY688 Ophthalmic Solution in Subjects With Dry Eye Disease | NCT04899518 | Allysta Pharmaceutical | user2@example.com | None | 2021-05-19 | 2023-03-14 | 2024-03-14 | - | - | 2025-07-14 |
| Phase 1/2a Safety and Efficacy of ALY688 Ophthalmic Solution in Subjects With Dry Eye Disease | NCT04201574 | Allysta Pharmaceutical | user2@example.com | None | 2019-12-16 | 2020-09-15 | 2021-09-15 | - | - | 2025-07-14 |
| ALY688-SR in Generally Healthy Overweight or Obese Adults | NCT04855565 | Allysta Pharmaceutical | user2@example.com | None | 2021-05-19 | 2021-08-03 | 2022-08-03 | - | - | 2025-07-14 |
| H-1337 Ophthalmic Solution Phase 1/2 | NCT03452033 | Allysta Pharmaceutical | user2@example.com | None | 2018-03-15 | 2018-08-15 | 2019-08-15 | - | - | 2025-07-14 |